期刊文献+

MGMT基因甲基化在胶质瘤化疗中的意义 被引量:4

下载PDF
导出
摘要 神经胶质瘤预后较差,化疗是其重要的辅助治疗手段之一,然而效果不理想,肿瘤耐药是影响化疗效果的重要原因。DNA修复蛋白O6-甲基鸟嘌呤-DNA-甲基转移酶(O6-methyl guanine-DNA-methyltrasferase,MGMT)在肿瘤耐药中的机制比较明确,而MGMT的表达与MGMT基因的甲基化状态呈密切相关。本文总结相关研究的进展,就MGMT基因甲基化状态与脑胶质瘤化疗的关系进行综述,为实现肿瘤个体化、预见性治疗提供理论依据。
出处 《中国临床神经外科杂志》 2010年第6期378-380,共3页 Chinese Journal of Clinical Neurosurgery
  • 相关文献

参考文献21

  • 1Watatani M,Ikenaga M,Hatanaka T,et al.Analysis of MNNG-induced DNA damage in tumor cell strains from Japanese patients and demonstration of MNNG hypersensitivity of merxenografts in athymic nude mice[J].Carcinogenesis,1985,6:549-553. 被引量:1
  • 2许洪升,张俊英,岳伟英,牟永告,张湘衡,赛克,陈忠平.脑胶质瘤MGMT表达与体外药敏相关性及其临床意义[J].中国临床神经外科杂志,2007,12(5):263-266. 被引量:8
  • 3黄强等主编..胶质瘤[M].北京:中国科学技术出版社,2000:630.
  • 4Mollemann M,Wolter M,Felsberg J,et al.Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendrogliol tumors[J].Int J Cander,2005,113(3):379-385. 被引量:1
  • 5Hegi ME,Diser AC,Gorlia S,et al.MGMT gene silencing and benefit from temozolomide in glioblastoma[J].N Engl Med,2005,352(10):997-1003. 被引量:1
  • 6Day RS,Ziolkowaki CHJ,Scudiero DA,et al.Defective repair of alkylated DNA by human tumor and SV-40 transeformed human cell strains[J].Nature,1980,288:724-727. 被引量:1
  • 7Mineura K,Yanagisawa T,Wantanabe K,et al.Human brain tumor O6 -methylguanine-DNA methyltranseferase mRNA and its significance as indicator of selective chloroethylnitrosourea chemotherapy[J].Int J Cancer,1996,69:420-. 被引量:1
  • 8Ashby L,Larocca R,Ryken T.Treatment of brain tumor[J].N Engl Med,2005,352(22):2350-2353. 被引量:1
  • 9Chibbaro S,Benvenuti L,Caprio A,et al.Temozolomide as first line agent in treating high grade gliomas:phaseⅡstudy[J].J Neurooncol,2004,67(1):77-81. 被引量:1
  • 10Kitange GJ,Carlson BL,Mladek AC,et al.Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model[J].J Neurooncol,2009,92:23-31. 被引量:1

二级参考文献16

  • 1张俊英,陈忠平.MGMT基因表达与人脑胶质瘤化疗耐药关系研究[J].中国神经肿瘤杂志,2003,1(4):200-204. 被引量:12
  • 2陈建文,张俊平,程金建,陈建良,史鸿浏,张俊英,牟永告,张湘衡,周旺宁,赛克,陈忠平.体外药敏试验指导的恶性脑胶质瘤预见性化疗[J].广东医学,2005,26(9):1183-1185. 被引量:17
  • 3颜子颖 王汝林译.精编分子生物学实验指南:第1版[M].北京:科学出版社,1998.39. 被引量:3
  • 4RogerStuppp.脑胶质瘤:替莫唑胺联合放疗优于单纯放疗[J].肿瘤时讯,2004,8(2):2-2. 被引量:1
  • 5Tanaka S,Kobayshi I,Utsuki S,et al.O6-methylguanine-DNA methyltransferase gene expression in gliomas by means of realtime quantitative RT-PCR and clinical response to nitrosoureas [ J].Int J Cander,2003,103 (1):67-72. 被引量:1
  • 6Yuan Q,Matsumoto K,Nakabeppu Y,et al.A comparative immunohistochemistry of O6-methylguanine-DNA methyltransferase and P53 in diffusely infiltrating astrocytomas[ J ].Neuropathology,2003,23(3):203-209. 被引量:1
  • 7Mollemann M,Wolter M,Felsberg J,et al.Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendrogliol tumors [ J ].Int J Cander,2005,113 (3):379-385. 被引量:1
  • 8Hegi ME,Diserens AC,Godard S,et al.Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide[J].Clin Cancer Res,2004,10(3):1871~1874. 被引量:1
  • 9Salinas AE,Wong MG.Glutathione S-transferases a review[J].Curr Med Chem,1999,6(4):279~309. 被引量:1
  • 10Ferreira CG,Tolis C,Giaccone G.p53 and chemosensitivity[J].Ann Oncol,1999,10(9):1011~1021. 被引量:1

共引文献27

同被引文献74

  • 1陈忠平.重视胶质瘤的规范化治疗[J].中国临床神经外科杂志,2007,12(5):257-258. 被引量:16
  • 2许洪升,张俊英,岳伟英,牟永告,张湘衡,赛克,陈忠平.脑胶质瘤MGMT表达与体外药敏相关性及其临床意义[J].中国临床神经外科杂志,2007,12(5):263-266. 被引量:8
  • 3卢俊章,杨正明.脑胶质瘤化疗敏感性实验研究[J].中国临床神经外科杂志,2007,12(5):267-269. 被引量:9
  • 4黄磊,江涛,袁芳,刘恩重.MGMT基因甲基化在胶质瘤化疗及预后中的意义[J].中国微侵袭神经外科杂志,2007,12(10):474-477. 被引量:9
  • 5Scaringi C,Minniti G,Caporello P. Integrin Inhibitor Cilengitide for the treatment of glioblastoma:A brief over-view of current clinical results[J].Anticancer Research,2012,(10):4213-4223. 被引量:1
  • 6Kohler BA,Ward E,McCarthy BJ. Annual report to the nation on the status of cancer, 1975-2007, featuring tu-mors of the brain and other nervous system[J].JOURNAL OF THE NATIONAL CANCER INSTITUTE,2011,(09):714-736. 被引量:1
  • 7Central Brain Tumor Registry of the United States. 2007-2008:Primary brain tumors in the United States, Sta-tistical report, 2000-2004[OL].http://www.cbtrus.org/re-ports/reports.html,2009. 被引量:1
  • 8Shirai K,Chakravarti A. Towards personalized therapy for patients with glioblastoma[J].EXPERT REVIEW OF ANTICANCER THERAPY,2011,(12):1935-1944. 被引量:1
  • 9Mikuni N,Miyamoto S. Surgical treatment for glioma:extent of resection applying function neurosurgery[J].Neurol Med Chir(Tokyo),2010,(09):720-726. 被引量:1
  • 10Sathornsumetee S,Rich JN,Reardon DA. Diagnosis and treatment of high-grade astrocytoma[J].NEUROLOGIC CLINICS,2007,(04):111-1139. 被引量:1

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部